Craft

Cooper Companies

Stock Price

$104.5

2024-10-29

Market Capitalization

$18.8 B

2024-08-26

Revenue

$4.1 B

FY, 2025

Cooper Companies Summary

Company Summary

Overview
The Cooper Companies is a global medical device company. The Company develops, manufactures and markets a range of contact lenses, including spherical lenses, toric and multifocal lenses that correct near— and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides medical devices, surgical instruments, accessories, and diagnostic products and services for health care professionals and institutions focusing on women’s health, fertility, and genetic testing in hospitals, clinician’s offices, and fertility clinics.
Type
Public
Status
Active
Founded
1958
HQ
San Ramon, CA, US | view all locations
Website
http://www.coopercos.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Albert G. White

    Albert G. White, President, Chief Executive Officer, Director

    • Daniel G. McBride

      Daniel G. McBride, Executive Vice President & Chief Operating Officer

    • William A. Kozy

      William A. Kozy, Director

      • Colleen E. Jay

        Colleen E. Jay, Director

        Operating MetricsView all

        Countries

        100

        May, 2018

        LocationsView all

        13 locations detected

        • San Ramon, CA HQ

          United States

          6101 Bollinger Canyon Rd #500

        • Carpinteria, CA

          United States

          1132 Mark Ave

        • Fairport, NY

          United States

          370 Woodcliff Dr

        • Trumbull, CT

          United States

          75 Corporate Dr

        • Victor, NY

          United States

          209 High Point Drive

        • Herstal, Région Wallonne

          Belgium

          1ère Avenue 32

        and 7 others

        Cooper Companies Financials

        Summary Financials

        Revenue (Q2, 2026)
        $1.1B
        Gross profit (Q2, 2026)
        $735.4M
        Net income (Q2, 2026)
        ($77.9M)
        Cash (Q1, 2026)
        $124.9M
        EBIT (Q2, 2026)
        ($31.0M)
        Enterprise value
        $21.1B

        Footer menu